Search

everythinglearnresearchcommunity

for

Search:↓

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Hair loss from multiple sclerosis treatments is usually temporary.

A woman with severe hair loss due to systemic sclerosis regrew her hair in 4 months using a combination of treatments.

The cat's skin condition was resistant to treatment and did not improve.

Skin tumor cells in patients with tuberous sclerosis have higher levels of a protein called cathepsin B.

Most patients with Tuberous sclerosis had neurological or skin issues, and over half had psychiatric problems.

Lichen sclerosus et atrophicus is generally not considered precancerous, but there are exceptions.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

NISCH syndrome is a rare genetic disorder affecting skin and liver, with variable symptoms and limited treatment options.

PEH in vulvar LS is common and needs careful diagnosis to avoid confusion with cancer.

Effective pain management in multiple sclerosis requires individualized treatment strategies.

PRP and ADSC therapies show promise in improving symptoms of genital lichen sclerosus with minimal side effects.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Hair thinning is a common but generally mild and reversible side effect of teriflunomide in multiple sclerosis patients.

Cord blood platelet-rich plasma may safely improve vulvar lichen sclerosus symptoms.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

A novel CLDN1 mutation in a 2-month-old with NISCH showed improvement with symptom management.

Being overweight, having gallbladder removal surgery, and taking cholesterol-lowering drugs are linked to a higher chance of getting vulvar lichen sclerosus.

Platelet-rich Plasma Gel may help treat en coup de sabre scleroderma, improving symptoms and skin quality with minimal side effects.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

The study concluded that patients with total hair loss and recurring hair loss had an earlier onset, longer-lasting condition, and a greater negative impact on their quality of life, with allergic conditions linked to more severe hair loss.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Unique fat cells near fibrotic areas contribute to systemic sclerosis progression.

Chaga mushrooms contain compounds that may promote hair growth better than common treatments.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Ocrelizumab may cause total body hair loss in some patients.

Isoflavones from soy may help manage multiple sclerosis symptoms, but more research is needed.